Clinical trial

Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.

NCT01991197

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-04-01

PhasePHASE2

Study timeline

Study start (unknown)2014-04-01Date precision: month

Registry last updated2020-05-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psoriasisunresolved

Type 2 Diabetes Mellitusunresolved

Interventions

SitagliptinDRUG · verified · RxNorm: sitagliptin

Sitagliptin matched placeboDRUG

Gliclazide matched placebo capsuleDRUG

Sponsors & collaborators

University College Dublinlead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01991197 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.